Description
Anti-TNFRSF12 (Enavatuzumab) -MC-Vc-PAB-MMAE ADC | ADC-W-1901 | Gentaur UK, US & Europe Distribution
Short Description: This ADC product is comprised of an anti-TNFRSF12 monoclonal antibody conjugated via a MC-Vc linker to MMAE
Status: In stock
Expected Delivery Time: 9-11Weeks